Skip to content
← Full study record

NCT01346267 · BASELINE

Baseline characteristics

Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy · Source last updated 2021-08-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      83
    2. group Id
      BG001
      value
      82
    3. group Id
      BG002
      value
      165
    units
    Participants
groups
  1. description
    Patients wear Sea-Band acupressure wristbands on each wrist beginning approximately 30 minutes prior to the first cisplatin-containing chemotherapy course and continually for 24 hours after the last chemotherapy dose (acute phase), and for a maximum of 7 days or until the next chemotherapy course starts (delayed phase). Patients are allowed to take bands off intermittently (up to 4 times a day, for no more than 15 minutes each time) to relieve pressure or to bathe. Patients also receive standard of care anti-emetic prophylaxis comprising granisetron, ondansetron, or dexamethasone during chemotherapy according to institutional or physician preference. Real Acupressure Band: Acupressure wristband
    id
    BG000
    title
    Arm I- Real Acupressure Bands
  2. description
    Patients wear placebo wristbands on each wrist and receive standard of care anti-emetic prophylaxis during chemotherapy as patients in arm I. Placebo Acupressure Band: Sham wristband
    id
    BG001
    title
    Arm II- Placebo Acupressure Bands
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          4.3
          value
          12.5
        2. group Id
          BG001
          spread
          4.2
          value
          12.9
        3. group Id
          BG002
          spread
          4.2
          value
          12.7
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          37
        2. group Id
          BG001
          value
          32
        3. group Id
          BG002
          value
          69
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          46
        2. group Id
          BG001
          value
          50
        3. group Id
          BG002
          value
          96
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          16
        2. group Id
          BG001
          value
          17
        3. group Id
          BG002
          value
          33
        title
        Osteosarcoma
      2. measurements
        1. group Id
          BG000
          value
          20
        2. group Id
          BG001
          value
          29
        3. group Id
          BG002
          value
          49
        title
        Hodgkin Lymphoma
      3. measurements
        1. group Id
          BG000
          value
          9
        2. group Id
          BG001
          value
          6
        3. group Id
          BG002
          value
          15
        title
        Ewing Sarcoma
      4. measurements
        1. group Id
          BG000
          value
          38
        2. group Id
          BG001
          value
          30
        3. group Id
          BG002
          value
          68
        title
        Other
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Diagnosis
    unit Of Measure
    Participants
population Description
93 participants were allocated to acupressure bands and 83 received the intervention. 94 participants were allocated to the placebo bands and 82 received the intervention.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      83
    2. group Id
      BG001
      value
      82
    3. group Id
      BG002
      value
      165
    units
    Participants
groups
  1. description
    Patients wear Sea-Band acupressure wristbands on each wrist beginning approximately 30 minutes prior to the first cisplatin-containing chemotherapy course and continually for 24 hours after the last chemotherapy dose (acute phase), and for a maximum of 7 days or until the next chemotherapy course starts (delayed phase). Patients are allowed to take bands off intermittently (up to 4 times a day, for no more than 15 minutes each time) to relieve pressure or to bathe. Patients also receive standard of care anti-emetic prophylaxis comprising granisetron, ondansetron, or dexamethasone during chemotherapy according to institutional or physician preference. Real Acupressure Band: Acupressure wristband
    id
    BG000
    title
    Arm I- Real Acupressure Bands
  2. description
    Patients wear placebo wristbands on each wrist and receive standard of care anti-emetic prophylaxis during chemotherapy as patients in arm I. Placebo Acupressure Band: Sham wristband
    id
    BG001
    title
    Arm II- Placebo Acupressure Bands
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          4.3
          value
          12.5
        2. group Id
          BG001
          spread
          4.2
          value
          12.9
        3. group Id
          BG002
          spread
          4.2
          value
          12.7
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          37
        2. group Id
          BG001
          value
          32
        3. group Id
          BG002
          value
          69
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          46
        2. group Id
          BG001
          value
          50
        3. group Id
          BG002
          value
          96
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          16
        2. group Id
          BG001
          value
          17
        3. group Id
          BG002
          value
          33
        title
        Osteosarcoma
      2. measurements
        1. group Id
          BG000
          value
          20
        2. group Id
          BG001
          value
          29
        3. group Id
          BG002
          value
          49
        title
        Hodgkin Lymphoma
      3. measurements
        1. group Id
          BG000
          value
          9
        2. group Id
          BG001
          value
          6
        3. group Id
          BG002
          value
          15
        title
        Ewing Sarcoma
      4. measurements
        1. group Id
          BG000
          value
          38
        2. group Id
          BG001
          value
          30
        3. group Id
          BG002
          value
          68
        title
        Other
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Diagnosis
    unit Of Measure
    Participants
population Description
93 participants were allocated to acupressure bands and 83 received the intervention. 94 participants were allocated to the placebo bands and 82 received the intervention.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice